当前位置:首页 - 行情中心 - 仁度生物(688193) - 财务分析 - 现金流量表

仁度生物

(688193)

  

流通市值:20.91亿  总市值:20.91亿
流通股本:4006.99万   总股本:4006.99万

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金86,799,630.4242,696,759.4202,644,446.67136,587,362.1
  收到的税费返还61,133.23--4,859.64
  收到其他与经营活动有关的现金3,117,450.39186,150.184,643,813.763,246,369.6
  经营活动现金流入的平衡项目0-0.0100
  经营活动现金流入小计89,978,214.0442,882,909.57207,288,260.43139,838,591.34
  购买商品、接受劳务支付的现金17,201,280.6110,807,089.4926,753,149.3419,160,845.05
  支付给职工以及为职工支付的现金31,913,458.3517,864,234.476,696,581.2158,802,412.82
  支付的各项税费12,741,731.16,907,301.4817,735,837.8311,423,288.91
  支付其他与经营活动有关的现金30,176,684.8517,430,576.7663,695,619.2144,692,638.71
  经营活动现金流出小计92,033,154.9153,009,202.13184,881,187.59134,079,185.49
  经营活动产生的现金流量净额-2,054,940.87-10,126,292.5622,407,072.845,759,405.85
二、投资活动产生的现金流量:
  收回投资收到的现金1,099,151,910354,184,4602,063,000,0001,393,000,000
  取得投资收益收到的现金7,813,035.943,362,434.7311,066,403.625,789,824.72
  处置固定资产、无形资产和其他长期资产收回的现金净额--209,569.424,600
  投资活动现金流入小计1,106,964,945.94357,546,894.732,074,275,973.041,398,794,424.72
  购建固定资产、无形资产和其他长期资产支付的现金--7,074,497.891,500,981.63
  投资支付的现金1,025,000,000350,000,0002,243,000,0001,513,969,827.68
  投资活动现金流出小计1,025,000,000350,000,0002,250,074,497.891,515,470,809.31
  投资活动产生的现金流量净额81,964,945.947,546,894.73-175,798,524.85-116,676,384.59
三、筹资活动产生的现金流量:
  吸收投资收到的现金--2,627,1122,627,112
  收到其他与筹资活动有关的现金---65,256
  筹资活动现金流入平衡项目--00
  筹资活动现金流入小计--2,627,1122,692,368
  分配股利、利润或偿付利息支付的现金38,778,442-9,687,623.53,870,857.2
  支付其他与筹资活动有关的现金1,313,166.94925,389.142,479,842.182,128,872.75
  筹资活动现金流出小计40,091,608.94925,389.1412,167,465.685,999,729.95
  筹资活动产生的现金流量净额-40,091,608.94-925,389.14-9,540,353.68-3,307,361.95
四、汇率变动对现金及现金等价物的影响-288,543.81-154,945.64-1,211,864.5847,065.72
  现金及现金等价物净增加额平衡项目00.0100
五、现金及现金等价物净增加额39,529,852.32-3,659,732.6-164,143,670.19-113,377,274.97
  加:期初现金及现金等价物余额97,434,315.6397,434,315.63261,577,985.82261,577,985.82
  期末现金及现金等价物余额136,964,167.9593,774,583.0397,434,315.63148,200,710.85
补充资料:
  净利润9,575,519.87-10,087,386.2-
  资产减值准备621,844.51-1,947,447.67-
  固定资产和投资性房地产折旧6,587,556.35-13,478,648.43-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧6,587,556.35-13,478,648.43-
  无形资产摊销72,603.64-202,737.81-
  长期待摊费用摊销1,421,889-2,883,959.08-
  处置固定资产、无形资产和其他长期资产的损失-14,898.14-386,313.64-
  固定资产报废损失321,440.66-104,923.24-
  公允价值变动损失1,317,068--3,624,066.22-
  财务费用248,257.15-334,840.73-
  投资损失-8,462,006.67--10,106,748.06-
  递延所得税743,301.17-131,657.34-
  其中:递延所得税资产减少743,301.17-131,657.34-
  存货的减少2,236,334.7-3,914,380-
  经营性应收项目的减少-6,459,997.12-19,803,028.48-
  经营性应付项目的增加-11,413,064.8--5,646,059.35-
  其他-773,763.7--2,140,849.8-
  现金的期末余额136,964,167.95-97,434,315.63-
  减:现金的期初余额97,434,315.63-261,577,985.82-
  现金及现金等价物的净增加额39,529,852.32--164,143,670.19-
公告日期2026-08-292026-04-292026-04-292025-10-31
审计意见(境内)标准无保留意见
TOP↑